Biotech Series C Investors & VC Firms
600 firms in this list, with a median first check of $1M. 112 of them lead rounds. Generated from verified public data and updated continuously.
Forbion
NaardenPre-Seed–Late Stage
24 people
Hadean Ventures
OsloSeed–Growth
21 people
TVM Capital
MunichSeed–Late Stage$1.1M – $16.2M
22 people
Inkef
AmsterdamSeed–Growth
14 people
Starquest Capital
ParisSeed–Growth$530K – $21.2M
14 people
Creathor Ventures
Bad HomburgSeed–Late Stage$540K – $10.8M
3 people
Neva Sgr.
TurinSeries A–Growth
12 people
The March Group
DavisPre-Seed–Late Stage
21 people
Venture Ontario
TorontoSeed–Growth
3 people
Sixty Degree Capital
North YorkPre-Seed–Late Stage
19 people
Hiroshima Venture Capital Co. Ltd.
HiroshimaPre-Seed–Late Stage
DG Incubation
Pre-Seed–Growth
1 person
Lilly Asia Ventures
Hong KongPre-Seed–Late Stage
1 person
Limburgse Reconversie Maatschappij
HasseltSeed–Late Stage$27K – $10.8M
22 people
New Alliance Capital
ShanghaiSeed–Late Stage
25 people
Sciety
StockholmSeed–Growth
21 people
Fast Track Initiative
TokyoPre-Seed–Growth$1.2M – $184M
2 people
Dimension Capital
San FranciscoSeed–Late Stage$1M – $10M
13 people
Quan Capital
ShanghaiSeed–Late Stage
16 people
UCL Technology Fund
LondonPre-Seed–Growth$320K – $9M
13 people
Ajax Health
Menlo ParkSeed–Late Stage
23 people
Better Ventures Central Llc
OaklandPre-Seed–Growth$500K – $1.5M
4 people
Tenmile
Seed–Growth
11 people
MaRS
TorontoPre-Seed–Late Stage
19 people
Related lists
Series C Investors & VC Firms (2751)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Biotech Series A Investors & VC Firms (1596)Biotech Investors & VC Firms in United States (1039)Series C Investors & VC Firms in United States (946)Biotech Series B Investors & VC Firms (900)Series C Investors & VC Firms in Global (896)Biotech Pre-Seed Investors & VC Firms (896)Healthtech Series C Investors & VC Firms (771)
Data sourced from public filings and firms' own websites — see our methodology.












.jpg)






.webp)


.png)








































